| Overview |
| bsm-54428R |
| O-GlcNAcase (1A5) Monoclonal Antibody |
| WB, IHC-P, IP |
| Human, Mouse |
| Specifications |
| Unconjugated |
| Rabbit |
| Recombinant protein of N-terminal human MGEA5. |
| Monoclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C for 12 months. |
| Target |
| 10724 |
| O60502 |
| Cytoplasm, Nucleus |
| Protein O-GlcNAcase; Beta-N-acetylglucosaminidase; Beta-N-acetylhexosaminidase; Beta-hexosaminidase; Meningioma-expressed antigen 5; N-acetyl-beta-D-glucosaminidase; N-acetyl-beta-glucosaminidase; Nuclear cytoplasmic O-GlcNAcase and acetyltransferase; OGA; NCOAT; MGEA5; HEXC; KIAA0679; MEA5 |
| Isoform 1: - Cleaves GlcNAc but not GalNAc from O-glycosylated proteins. Can use p-nitrophenyl-beta-GlcNAc and 4-methylumbelliferone-GlcNAc as substrates but not p-nitrophenyl-beta-GalNAc or p-nitrophenyl-alpha-GlcNAc (in vitro). Does not bind acetyl-CoA and does not have histone acetyltransferase activity. Isoform 3: - Cleaves GlcNAc but not GalNAc from O-glycosylated proteins. Can use p-nitrophenyl-beta-GlcNAc as substrate but not p-nitrophenyl-beta-GalNAc or p-nitrophenyl-alpha-GlcNAc (in vitro), but has about six times lower specific activity than isoform 1. |
| Application Dilution |
| WB |
1:300-5000 |
| IHC-P |
1:200-400 |
| IP |
1-2ug |